| Literature DB >> 33664170 |
RohanKumar Ochani1, Ameema Asad1, Farah Yasmin1, Shehryar Shaikh1, Hiba Khalid1, Simran Batra1, Muhammad Rizwan Sohail2, Syed Faisal Mahmood3, Rajkumar Ochani4, Mohammad Hussham Arshad5, Arjan Kumar6, Salim Surani7.
Abstract
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. COVID-19 pandemic has overburdened healthcare systems in most countries and has led to massive economic losses. SARS-CoV-2 transmission typically occurs by respiratory droplets. The average incubation period is 6.4 days and presenting symptoms typically include fever, cough, dyspnea, myalgia or fatigue. While the majority of patients tend to have a mild illness, a minority of patients develop severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly supportive. However, several direct anti-viral agents, and immunomodulatory therapy with steroids and various cytokine blockers seem promising in early results. However, an effective vaccine has been established, which will help curb the pandemic.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33664170
Source DB: PubMed Journal: Infez Med ISSN: 1124-9390